For the FDA advisory panel discussion of Epitalon, see FDA Advisory Panel Day 2 Results: Semax and Epitalon Recommended, Emideltide Rejected.
What Is Epitalon?
Epitalon, also spelled Epithalon, is a synthetic tetrapeptide (Ala-Glu-Asp-Gly, AEDG) based on the natural peptide Epithalamin, isolated from the pineal gland by Professor Vladimir Khavinson. It holds the distinction of being among the first compounds shown to activate telomerase and elongate telomeres in human somatic cells — a finding with profound implications for aging biology. It was developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.
Telomere Biology
Telomeres are protective DNA caps at the ends of chromosomes that shorten with each cell division. When they reach a critical minimum length, cells enter senescence or apoptosis — fundamentally linked to cellular aging. Epitalon has been shown in multiple in vitro studies to activate telomerase, producing measurable telomere elongation in aging human cells — one of the only documented non-enzymatic mechanisms for pharmacological telomere elongation.
Longevity Research
Long-term studies in rodents using Epitalon consistently show life extension of 10–25% compared to controls. It also stimulates the pineal gland to produce melatonin by restoring pinealocyte sensitivity to neuroendocrine signals that decline with age, contributing to improvements in sleep quality, antioxidant defense, and circadian rhythmicity observed in both animal and human studies. Human studies in Russia have reported reduced cancer incidence and improved cardiovascular outcomes in cohorts receiving periodic Epitalon courses.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Peptide correction of age-related pineal disturbances in monkeys
Khavinson, V.Kh., Bondarev, I.E., Butyugov, A.A., 2003, Bulletin of Experimental Biology and Medicine - Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice
Anisimov, V.N., Khavinson, V.Kh., Morozov, V.G., 2003, Biogerontology - Geroprotective effect of thymalin and epithalamin
Labunets, I.F., Khavinson, V.Kh., Stepanyuk, G.I., 2002, Bulletin of Experimental Biology and Medicine - Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice
Kossoy, G., Anisimov, V.N., Ben-Hur, H., Kossoy, N., 2006, In Vivo - Overview of Epitalon—Highly Bioactive Pineal Tetrapeptide with Promising Properties
Ashapkin, V.V., Kutueva, L.I., Kurchashova, S.Y., 2025, International Journal of Molecular Sciences - Biomedical journals and databases in Russia and Russian language translation issues
Varga, J.L., Matkovics, A., Dévai, G., 2008, Journal of the Medical Library Association - Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties
Araj SK, Brzezik J, Mądra-Gackowska K, 2025, Int J Mol Sci - Identification of the small research tetra peptide Epitalon, assumed to be a potential treatment for cancer, old age and Retinitis Pigmentosa in two illegal pharmaceutical preparations
Vanhee C, Moens G, Van Hoeck E, 2015, Drug Test Anal - Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice
Kossoy G, Anisimov VN, Ben-Hur H, 2006, In Vivo - Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
Anisimov VN, Khavinson VK, Provinciali M, 2002, Int J Cancer - Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats
Anisimov VN, Khavinson VKh, Popovich IG, 2002, Cancer Lett - Khavinson development attribution. Avolio et al. Int J Mol Sci. 2022;23(7):3607. Khavinson peptide attribution.; Khavinson et al. Bull Exp Biol Med. 2017;164(1):41–43. Identification of peptide AEDG.; Khavinson et al. Molecules. 2020;25(3):609. AEDG peptide (Epitalon).
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural peptide Epithalamin, isolated from the pineal gland by Professor Vladimir Khavinson. It holds the distinction of being among the first compounds shown to activate telomerase and elongate telomeres in human somatic cells — a finding with profound implications for aging biology.